# Europe-Africa Research Network for Evaluation of Second-line Therapy

> **NCT00988039** · PHASE3 · COMPLETED · sponsor: **Justine Boles** · enrollment: 1277 (actual)

## Conditions studied

- Human Immunodeficiency Virus
- HIV

## Interventions

- **DRUG:** Aluvia + 2NRTIs
- **DRUG:** Aluvia + raltegravir
- **DRUG:** Aluvia monotherapy

## Key facts

- **NCT ID:** NCT00988039
- **Lead sponsor:** Justine Boles
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 1277 (ACTUAL)
- **Last updated:** 2014-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00988039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00988039, "Europe-Africa Research Network for Evaluation of Second-line Therapy". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00988039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*